Multiomic Health is a next-generation precision medicine business, applying computational systems biology and artificial intelligence to develop precision therapeutics for conditions related to metabolic syndrome.
First Year of Investment 2023
Type of Investment Early Stage
Investment Status Current
Investment Lead Charlotte Barttelot
Metabolic syndrome, a cluster of closely-related diseases such atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver, is considered the most significant cause of death globally.
With its unique combination of data science and biology expertise, MultiOmic Health enables the data-driven development of therapeutics.